• 76600 Citations
  • 135 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

A heavy metal baseline score predicts outcome in acute myeloid leukemia

Ohanian, M., Telouk, P., Kornblau, S., Albarede, F., Ruvolo, P., Tidwell, R. S. S., Plesa, A., Kanagal-Shamanna, R., Matera, E. L., Cortes, J., Carson, A. & Dumontet, C., Jan 1 2020, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

Samra, B., Richard-Carpentier, G., Kadia, T. M., Ravandi, F., Daver, N., DiNardo, C. D., Issa, G. C., Bose, P., Konopleva, M. Y., Yilmaz, M., Ohanian, M., Borthakur, G., Garcia-Manero, G., Pierce, S., Cortes, J. E., Kantarjian, H. & Short, N. J., May 1 2020, In : Blood Cancer Journal. 10, 5, 47.

Research output: Contribution to journalArticle

Open Access

Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia

Kolitz, J. E., Strickland, S. A., Cortes, J. E., Hogge, D., Lancet, J. E., Goldberg, S. L., Villa, K. F., Ryan, R. J., Chiarella, M., Louie, A. C., Ritchie, E. K. & Stuart, R. K., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 631-640 10 p.

Research output: Contribution to journalArticle

Open Access

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

Cortes, J. E., Jiang, Q., Wang, J., Weng, J., Zhu, H., Liu, X., Hochhaus, A., Kim, D. W., Radich, J., Savona, M., Martin-Regueira, P., Sy, O., Gurnani, R. & Saglio, G., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access

Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia

Dao, K. H. T., Gotlib, J., Deininger, M. M. N., Oh, S. T., Cortes, J. E., Collins, R. H., Winton, E. F., Parker, D. R., Lee, H., Schultz, A. R., Stevens, S. S., Brockett, C., Subbiah, N., Press, R. D., Raess, P. W., Cascio, M., Dunlap, J., Chen, Y., Degnin, C., Maxson, J. E. & 4 others, Tognon, C. E., Macey, T., Druker, B. J. & Tyner, J. W., Apr 1 2020, In : Journal of Clinical Oncology. 38, 10, p. 1006-1018 13 p.

Research output: Contribution to journalArticle

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F. & 14 others, Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A. & Hehlmann, R., Apr 1 2020, In : Leukemia. 34, 4, p. 966-984 19 p.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia

Abou Dalle, I., Ghorab, A., Patel, K., Wang, X., Hwang, H., Cortes, J., Issa, G. C., Yalniz, F., Sasaki, K., Chihara, D., Price, A., Kadia, T., Pemmaraju, N., Daver, N., DiNardo, C., Ravandi, F., Kantarjian, H. M. & Borthakur, G., May 1 2020, In : Blood Cancer Journal. 10, 5, 48.

Research output: Contribution to journalArticle

Open Access

Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia

Sasaki, K., Kanagal-Shamanna, R., Montalban-Bravo, G., Assi, R., Jabbour, E., Ravandi, F., Kadia, T., Pierce, S., Takahashi, K., Nogueras Gonzalez, G., Patel, K., Soltysiak, K. A., Cortes, J., Kantarjian, H. M. & Garcia-Manero, G., Feb 15 2020, In : Cancer. 126, 4, p. 765-774 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia

Naqvi, K., Jabbour, E., Skinner, J., Anderson, K., Dellasala, S., Yilmaz, M., Ferrajoli, A., Bose, P., Thompson, P., Alvarado, Y., Jain, N., Takahashi, K., Burger, J., Estrov, Z., Borthakur, G., Pemmaraju, N., Paul, S., Cortes, J. & Kantarjian, H. M., Jan 1 2020, In : Cancer. 126, 1, p. 67-75 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

Masarova, L., Cortes, J. E., Patel, K. P., O’Brien, S., Nogueras-Gonzalez, G. M., Konopleva, M., Verstovsek, S., Garcia-Manero, G., Ferrajoli, A., Kadia, T. M., Ravandi-Kashani, F., Borthakur, G., DellaSala, S., Estrov, Z., Jabbour, E. J. & Kantarjian, H. M., Apr 1 2020, In : Cancer. 126, 7, p. 1448-1459 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Long-term results of frontline dasatinib in chronic myeloid leukemia

Maiti, A., Cortes, J. E., Patel, K. P., Masarova, L., Borthakur, G., Ravandi, F., Verstovsek, S., Ferrajoli, A., Estrov, Z., Garcia-Manero, G., Kadia, T. M., Nogueras-González, G. M., Skinner, J., Poku, R., DellaSala, S., Luthra, R., Jabbour, E. J., O’Brien, S. & Kantarjian, H. M., Apr 1 2020, In : Cancer. 126, 7, p. 1502-1511 10 p.

Research output: Contribution to journalArticle

1 Scopus citations

Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy

Montalban-Bravo, G., Kanagal-Shamanna, R., Class, C. A., Sasaki, K., Ravandi, F., Cortes, J. E., Daver, N., Takahashi, K., Short, N. J., DiNardo, C. D., Jabbour, E., Borthakur, G., Naqvi, K., Issa, G. C., Konopleva, M., Khoury, J. D., Routbort, M., Pierce, S., Do, K. A., Bueso-Ramos, C. & 4 others, Patel, K., Kantarjian, H., Garcia-Manero, G. & Kadia, T. M., Jan 1 2020, (Accepted/In press) In : American Journal of Hematology. 95, 6, p. 612-622 11 p.

Research output: Contribution to journalArticle

Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia

Sasaki, K., Kantarjian, H., Wierda, W., Ravandi-Kashani, F., Jorgensen, J., Wang, S. A., Khoury, J., Daver, N., Burger, J., Di Nardo, C. D., Jain, N., Short, N. J., Estrov MD, Z., Konopleva MD, PhD, M., Ohanian DO, M., Garcia-Manero, G., Kadia, T., Alvarado-Valero, Y., Yilmaz, M., Pierce, S. & 5 others, Garris, R., Ingram, A., Cortes, J., OʼBrien, S. & Jabbour, E., Jan 1 2020, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

Montesinos, P., Roboz, G. J., Bulabois, C. E., Subklewe, M., Platzbecker, U., Ofran, Y., Papayannidis, C., Wierzbowska, A., Shin, H. J., Doronin, V., Deneberg, S., Yeh, S. P., Ozcan, M. A., Knapper, S., Cortes, J., Pollyea, D. A., Ossenkoppele, G., Giralt, S., Döhner, H., Heuser, M. & 5 others, Xiu, L., Singh, I., Huang, F., Larsen, J. S. & Wei, A. H., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access

The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival

Yilmaz, M., Kantarjian, H., Wang, X., Khoury, J. D., Ravandi, F., Jorgensen, J., Short, N. J., Loghavi, S., Cortes, J., Garcia-Manero, G., Kadia, T., Sasaki, K., Konopleva, M., Takahashi, K., Wierda, W., Jain, N., Verstovsek, S., Estrov, Z., Bose, P., Pierce, S. & 3 others, Garris, R., O'Brien, S. & Jabbour, E., Feb 1 2020, In : American Journal of Hematology. 95, 2, p. 144-150 7 p.

Research output: Contribution to journalArticle

Treatment patterns and deep molecular response in chronic phase–chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study

Cortes, J., Huynh, L., Mendelson, E., Brandt, P., Dalal, D., DerSarkissian, M., Cortina, D., Narkhede, S. & Sheng Duh, M., Jan 2 2020, In : Leukemia and Lymphoma. 61, 1, p. 98-107 10 p.

Research output: Contribution to journalArticle

Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias

Maiti, A., Franquiz, M. J., Ravandi, F., Cortes, J. E., Jabbour, E. J., Sasaki, K., Marx, K., Daver, N. G., Kadia, T. M., Konopleva, M. Y., Masarova, L., Borthakur, G., Dinardo, C. D., Naqvi, K., Pierce, S., Kantarjian, H. M. & Short, N. J., Jan 1 2020, (Accepted/In press) In : Acta Haematologica.

Research output: Contribution to journalArticle

2019

Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs

Jain, P., Kantarjian, H., Boddu, P. C., Nogueras-González, G. M., Verstovsek, S., Garcia-Manero, G., Borthakur, G., Sasaki, K., Kadia, T. M., Sam, P., Ahaneku, H., O’Brien, S., Estrov, Z., Ravandi, F., Jabbour, E. & Cortes, J. E., Mar 26 2019, In : Blood Advances. 3, 6, p. 851-861 11 p.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Asciminib in chronic myeloid leukemia after Abl kinase inhibitor failure

Hughes, T. P., Mauro, M. J., Cortes, J. E., Minami, H., Rea, D., DeAngelo, D. J., Breccia, M., Goh, Y. T., Talpaz, M., Hochhaus, A., Coutre, P. L., Ottmann, O., Heinrich, M. C., Steegmann, J. L., Deininger, M. W. N., Janssen, J. J. W. M., Mahon, F. X., Minami, Y., Yeung, D., Ross, D. M. & 10 others, Tallman, M. S., Park, J. H., Druker, B. J., Hynds, D., Duan, Y., Meille, C., Hourcade-Potelleret, F., Vanasse, K. G., Lang, F. & Kim, D. W., Dec 12 2019, In : New England Journal of Medicine. 381, 24, p. 2315-2326 12 p.

Research output: Contribution to journalArticle

8 Scopus citations

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

Pemmaraju, N., Kantarjian, H., Nastoupil, L., Dupuis, M., Zhou, L., Pierce, S., Patel, K. P., Masarova, L., Cortes, J. & Verstovsek, S., May 23 2019, In : Blood. 133, 21, p. 2348-2351 4 p.

Research output: Contribution to journalArticle

13 Scopus citations

Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: A pooled analysis of individual patient data from nine international cohorts

Angenendt, L., Röllig, C., Montesinos, P., Martínez-Cuadrón, D., Barragan, E., García, R., Botella, C., Martínez, P., Ravandi, F., Kadia, T., Kantarjian, H. M., Cortes, J., Juliusson, G., Lazarevic, V., Höglund, M., Lehmann, S., Recher, C., Pigneux, A., Bertoli, S., Dumas, P. Y. & 25 others, Dombret, H., Preudhomme, C., Micol, J. B., Terré, C., Ráčil, Z., Novák, J., Žák, P., Wei, A. H., Tiong, I. S., Wall, M., Estey, E., Shaw, C., Exeler, R., Wagenführ, L., Stölzel, F., Thiede, C., Stelljes, M., Lenz, G., Mikesch, J. H., Serve, H., Ehninger, G., Berdel, W. E., Kramer, M., Krug, U. & Schliemann, C., Oct 10 2019, In : Journal of Clinical Oncology. 37, 29, p. 2632-2642 11 p.

Research output: Contribution to journalArticle

6 Scopus citations

Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia

Cortes, J. E., Jonas, B. A., Graef, T., Luan, Y. & Stein, A. S., Aug 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 8, p. 509-515.e1

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Zhang, H., Savage, S., Schultz, A. R., Bottomly, D., White, L., Segerdell, E., Wilmot, B., McWeeney, S. K., Eide, C. A., Nechiporuk, T., Carlos, A., Henson, R., Lin, C., Searles, R., Ho, H., Lam, Y. L., Sweat, R., Follit, C., Jain, V., Lind, E. & 10 others, Borthakur, G., Garcia-Manero, G., Ravandi, F., Kantarjian, H. M., Cortes, J., Collins, R., Buelow, D. R., Baker, S. D., Druker, B. J. & Tyner, J. W., Dec 1 2019, In : Nature communications. 10, 1, 244.

Research output: Contribution to journalArticle

Open Access
16 Scopus citations
2 Scopus citations

Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/ refractory acute myeloid leukemia: A nonrandomized, open-label, phase II study

Daver, N., Garcia-Manero, G., Basu, S., Boddu, P. C., Alfayez, M., Cortes, J. E., Konopleva, M., Ravandi-Kashani, F., Jabbour, E., Kadia, T., Nogueras-Gonzalez, G. M., Ning, J., Pemmaraju, N., Dinardo, C. D., Andreeff, M., Pierce, S. A., Gordon, T., Kornblau, S. M., Flores, W., Alhamal, Z. & 7 others, Bueso-Ramos, C., Jorgensen, J. L., Patel, K. P., Blando, J., Allison, J. P., Sharma, P. & Kantarjian, H., Mar 1 2019, In : Cancer Discovery. 9, 3, p. 370-383 14 p.

Research output: Contribution to journalArticle

Open Access
46 Scopus citations

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States

Abou Dalle, I., Kantarjian, H., Burger, J., Estrov, Z., Ohanian, M., Verstovsek, S., Ravandi, F., Borthakur, G., Garcia-Manero, G., Jabbour, E. & Cortes, J., Nov 1 2019, In : Cancer Medicine. 8, 15, p. 6559-6565 7 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML)

Lindsley, R. C., Gibson, C. J., Murdock, H. M., Stone, R. M., Cortes, J. E., Uy, G. L., Lin, T. L., Ritchie, E. K., Prebet, T., Ryan, R. J., Faderl, S. & Lancet, J. E., Nov 13 2019, In : Blood. 134, 1, 1 p.

Research output: Contribution to journalArticle

Germline genetic predisposition to myeloid neoplasia from GATA2 gene mutations: Lessons learned from two cases

Dalle, I. A., Bannon, S. A., Patel, K. P., Routbort, M. J., Cortes, J. E., Ferrajoli, A., Kontoyiannis, D. P., Wang, S. A. & DiNardo, C. D., Jan 1 2019, In : JCO Precision Oncology. 3

Research output: Contribution to journalArticle

Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

Perl, A. E., Martinelli, G., Cortes, J. E., Neubauer, A., Berman, E., Paolini, S., Montesinos, P., Baer, M. R., Larson, R. A., Ustun, C., Fabbiano, F., Erba, H. P., Di Stasi, A., Stuart, R., Olin, R., Kasner, M., Ciceri, F., Chou, W. C., Podoltsev, N., Recher, C. & 11 others, Yokoyama, H., Hosono, N., Yoon, S. S., Lee, J. H., Pardee, T., Fathi, A. T., Liu, C., Hasabou, N., Liu, X., Bahceci, E. & Levis, M. J., Oct 31 2019, In : New England Journal of Medicine. 381, 18, p. 1728-1740 13 p.

Research output: Contribution to journalArticle

34 Scopus citations

Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials

Cortes, J. E., Dombret, H., Merchant, A., Tauchi, T., Dirienzo, C. G., Sleight, B., Zhang, X., Leip, E. P., Shaik, N., Bell, T., Chan, G. & Sekeres, M. A., Jan 1 2019, In : Future Oncology. 15, 31, p. 3531-3545 15 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Hedgehog signaling inhibitors in solid and hematological cancers

Cortes, J. E., Gutzmer, R., Kieran, M. W. & Solomon, J. A., Jun 2019, In : Cancer Treatment Reviews. 76, p. 41-50 10 p.

Research output: Contribution to journalReview article

Open Access
8 Scopus citations

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study

Ravandi, F., Assi, R., Daver, N., Benton, C. B., Kadia, T., Thompson, P. A., Borthakur, G., Alvarado, Y., Jabbour, E. J., Konopleva, M., Takahashi, K., Kornblau, S., DiNardo, C. D., Estrov, Z., Flores, W., Basu, S., Allison, J., Sharma, P., Pierce, S., Pike, A. & 3 others, Cortes, J. E., Garcia-Manero, G. & Kantarjian, H. M., Sep 2019, In : The Lancet Haematology. 6, 9, p. e480-e488

Research output: Contribution to journalArticle

7 Scopus citations

Improving attribution of adverse events in oncology clinical trials

George, G. C., Barata, P. C., Campbell, A., Chen, A., Cortes, J. E., Hyman, D. M., Jones, L., Karagiannis, T., Klaar, S., Le-Rademacher, J. G., LoRusso, P., Mandrekar, S. J., Merino, D. M., Minasian, L. M., Mitchell, S. A., Montez, S., O'Connor, D. J., Pettit, S., Silk, E., Sloan, J. A. & 6 others, Stewart, M., Takimoto, C. H., Wong, G. Y., Yap, T. A., Cleeland, C. S. & Hong, D. S., Jun 2019, In : Cancer Treatment Reviews. 76, p. 33-40 8 p.

Research output: Contribution to journalReview article

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for philadelphia chromosome-positive leukemia

Hughes, T. P., Laneuville, P., Rousselot, P., Snyder, D. S., Rea, D., Shah, N. P., Paar, D., Abruzzese, E., Hochhaus, A., Lipton, J. H. & Cortes, J. E., Jan 1 2019, In : Haematologica. 104, 1, p. 93-101 9 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Sasaki, K., Kantarjian, H. M., O’Brien, S., Ravandi, F., Konopleva, M., Borthakur, G., Garcia-Manero, G., Wierda, W. G., Daver, N., Ferrajoli, A., Takahashi, K., Jain, P., Rios, M. B., Pierce, S. A., Jabbour, E. J. & Cortes, J. E., May 3 2019, In : International Journal of Hematology. 109, 5, p. 545-552 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis

Jabbour, E. J., Sasaki, K., Ravandi, F., Short, N. J., Garcia-Manero, G., Daver, N., Kadia, T., Konopleva, M., Jain, N., Cortes, J., Issa, G. C., Jacob, J., Kwari, M., Thompson, P., Garris, R., Pemmaraju, N., Yilmaz, M., O’Brien, S. M. & Kantarjian, H. M., Aug 1 2019, In : Cancer. 125, 15, p. 2579-2586 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

Strati, P., Garcia-Manero, G., Zhao, C., Kadia, T., Borthakur, G., Konopleva, M., Daver, N., DiNardo, C. D., Short, N. J., Yilmaz, M., Naqvi, K., Alvarado, Y., Pierce, S. A., Cortes, J., Bueso-Ramos, C., Kantarjian, H. & Ravandi, F., Jul 2019, In : American Journal of Hematology. 94, 7, p. E188-E190

Research output: Contribution to journalLetter

Open Access

Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia

Benton, C. B., Boddu, P. C., DiNardo, C. D., Bose, P., Wang, F., Assi, R., Pemmaraju, N., Devendra, K. C., Pierce, S., Patel, K., Konopleva, M., Ravandi, F., Garcia-Manero, G., Kadia, T. M., Cortes, J., Kantarjian, H. M., Andreeff, M. & Verstovsek, S., Jun 1 2019, In : Cancer. 125, 11, p. 1855-1866 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

on behalf of the International CML Foundation Genomics Alliance, Aug 1 2019, In : Leukemia. 33, 8, p. 1835-1850 16 p.

Research output: Contribution to journalReview article

11 Scopus citations

Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia

Cortes, J. E., Muresan, B., Mamolo, C., Cappelleri, J. C., Crescenzo, R. J., Su, Y., Gambacorti-Passerini, C., Heeg, B. & Douglas Smith, B., Jan 1 2019, In : Current Medical Research and Opinion. 35, 9, p. 1615-1622 8 p.

Research output: Contribution to journalArticle

2 Scopus citations

MYC protein expression is an important prognostic factor in acute myeloid leukemia

Ohanian, M., Rozovski, U., Kanagal-Shamanna, R., Abruzzo, L. V., Loghavi, S., Kadia, T., Futreal, A., Bhalla, K., Zuo, Z., Huh, Y. O., Post, S. M., Ruvolo, P., Garcia-Manero, G., Andreeff, M., Kornblau, S., Borthakur, G., Hu, P., Medeiros, L. J., Takahashi, K., Hornbaker, M. J. & 10 others, Zhang, J., Nogueras-González, G. M., Huang, X., Verstovsek, S., Estrov, Z., Pierce, S., Ravandi, F., Kantarjian, H. M., Bueso-Ramos, C. E. & Cortes, J. E., Jan 2 2019, In : Leukemia and Lymphoma. 60, 1, p. 37-48 12 p.

Research output: Contribution to journalArticle

3 Scopus citations

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Rafei, H., Jabbour, E. J., Kantarjian, H., Sinicrope, K. D., Kamiya-Matsuoka, C., Mehta, R. S., Daver, N. G., Kadia, T. M., Naqvi, K., Cortes, J. & Konopleva, M., Nov 10 2019, In : Leukemia and Lymphoma. 60, 13, p. 3292-3295 4 p.

Research output: Contribution to journalLetter

New Tool for Monitoring Molecular Response in Patients with Chronic Myeloid Leukemia

Badar, T., Luthra, R., Kantarjian, H., Jabbour, E., Borthakur, G., Garcia-Manero, G., Huang, X., Singh, R., Alvarez, B., Austermiller, B., Morrison, T. B., Patel, K. P. & Cortes, J., Jan 1 2019, In : Applied Immunohistochemistry and Molecular Morphology. 27, 1, p. 33-39 7 p.

Research output: Contribution to journalArticle

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemia

Abbas, H. A., Ravandi, F., Loghavi, S., Patel, K. P., Borthakur, G., Kadia, T. M., Jabbour, E., Takahashi, K., Cortes, J., Issa, G. C., Konopleva, M., Kantarjian, H. M. & Short, N. J., Jun 2019, In : American Journal of Hematology. 94, 6, p. E158-E160

Research output: Contribution to journalLetter

Open Access
7 Scopus citations

Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy

Boddu, P., Jain, P., Borthakur, G., Verstovsek, S., Garcia-Manero, G., Daver, N., Kadia, T., Ravandi, F., Jabbour, E., Cortes, J. & Kantarjian, H., Nov 10 2019, In : Leukemia and Lymphoma. 60, 13, p. 3172-3180 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia

the BFORE Study Investigators, Jun 1 2019, In : Journal of Cancer Research and Clinical Oncology. 145, 6, p. 1589-1599 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia

Maiti, A., Naqvi, K., Kadia, T. M., Borthakur, G., Takahashi, K., Bose, P., Daver, N. G., Patel, A., Alvarado, Y., Ohanian, M., DiNardo, C. D., Cortes, J. E., Jabbour, E. J., Garcia-Manero, G., Kantarjian, H. M. & Ravandi, F., Mar 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 3, p. 142-148.e1

Research output: Contribution to journalArticle

9 Scopus citations

Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia

Gong, Z., Xu, M. L., Chen, M., Cui, W., Kantarjian, H. M., Cortes, J. E., Zhou, T., Tang, G., Wang, W., Medeiros, L. J. & Hu, S., Oct 1 2019, In : American Journal of Hematology. 94, 10, p. E256-E259

Research output: Contribution to journalLetter

Open Access

Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors

Abou Dalle, I., Kantarjian, H. M., Short, N. J., Konopleva, M., Jain, N., Garcia-Manero, G., Garris, R., Qiao, W., Cortes, J. E., O'Brien, S., Kebriaei, P., Kadia, T., Jabbour, E. & Ravandi, F., Dec 2019, In : American Journal of Hematology. 94, 12, p. 1388-1395 8 p.

Research output: Contribution to journalArticle

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

Lin, S., Shaik, N., Martinelli, G., Wagner, A. J., Cortes, J. & Ruiz-Garcia, A., Jan 1 2019, (Accepted/In press) In : Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Open Access